News Archive

McGowan Institute for Regenerative Medicine deputy director Stephen Badylak, DVM, PhD, MD, professor in the Department of Surgery and director of the Center for Pre-Clinical Tissue Engineering within the McGowan Institute, was honored with the 2019 Lifetime Achievement Award from Tissue Engineering and Regenerative Medicine International Society-Americas (TERMIS-AM).  The TERMIS-AM Lifetime Achievement Award was established to recognize an individual who has contributed immensely to the tissue engineering and regenerative medicine field. The award is presented to an individual whose work has impacted and assisted with laying the foundation stones for the field. Read More

William Federspiel, PhD, Director of the Medical Devices Laboratory of the McGowan Institute for Regenerative Medicine and the William Kepler Whiteford Professor in the Department of Bioengineering with secondary appointments in Chemical Engineering and Critical Care Medicine at the University of Pittsburgh, has been named a Fellow of the National Academy of Inventors (NAI).  Election to NAI Fellow status is the highest professional distinction accorded solely to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society. Academic inventors and innovators elected to the rank of NAI Fellow status have been nominated by their peers for outstanding contributions to innovation in areas such as patents and licensing, innovative discovery and technology, significant impact on society, and support and enhancement of innovation. The 2019 Fellows Gala and Induction Ceremony will take place on April 10, 2020, at The Heard Museum in Phoenix, AZ. Read More

The US-Ireland Alliance recently announced the 21st Class of George J. Mitchell Scholars and among the finalists was McKenzie Sicke, a bioengineering undergraduate at the University of Pittsburgh who works in the lab of McGowan Institute for Regenerative Medicine Bryan Brown, PhD, associate professor of bioengineering.  In Dr. Brown’s lab, she studies angiogenic response to polypropylene mesh implants in rabbit models. The George J. Mitchell Scholarship Program is a national, competitive scholarship that awards one year of postgraduate study in any discipline offered by institutions of higher learning in Ireland and Northern Ireland to up to 12 students annually. Read More

In celebration of his appointment, McGowan Institute for Regenerative Medicine affiliated faculty member John Kellum, MD, Endowed Chair in Critical Care Medicine Research, presented the December 9, 2019, Provost Inaugural Lecture.  His presentation was entitled “The Inconvenient Truth About Acute Kidney Injury.” Read More

It is with sadness that the McGowan Institute for Regenerative Medicine announces the passing of affiliated faculty member James Funderburgh, PhD. Read More

With its theme of Inspiration and Innovation, Fairfield University, Fairfield, Connecticut, hosted a recent TEDx on October 28, 2019. Read More

Cardiol Therapeutics Inc., a leader in the production of pharmaceutical cannabidiol (CBD) products and in the development of innovative cannabidiol medicines for heart disease, announced the formation of the Clinical Steering Committee (CSC) for a Phase 2 international trial in acute myocarditis using its CardiolRx™100 cannabidiol formulation. Read More

The Innovation Institute celebrated the University of Pittsburgh faculty, students and staff who are working to make their ideas and research discoveries have a real-world impact at the 14th Annual Celebration of Innovation, on November 20 at the Petersen Events Center Campus View Club. Read More

The University of Pittsburgh School of Dental Medicine is the first in the nation to establish opioid-free pain management guidelines for the vast majority of procedures performed in all of its clinics. Read More

The dopamine D2 receptor has a previously unobserved role in modulating Wnt expression and control of cell proliferation, according to a new study from the George Washington University (GW) and the University of Pittsburgh. The research, published in Scientific Reports, could have implications for the development of new therapeutics across multiple disciplines including nephrology, endocrinology, and psychiatry.  Zachary Freyberg, MD, PhD, an assistant professor of psychiatry and cell biology at the University of Pittsburgh School of Medicine and an affiliated faculty member of the McGowan Institute for Regenerative Medicine, is a senior author on the study. Read More